Home Personal Care Johnson & Johnson, Eli Lilly Pause COVID-19 Drug Trials

Johnson & Johnson, Eli Lilly Pause COVID-19 Drug Trials

Oct 14, 2020 comments off

The phase 3 trial of Johnson & Johnson

The move by Eli Lilly came less than 24 hours after Johnson & Johnson paused further dosing in all of its COVID-19 vaccine candidate clinical trials while it investigated a volunteer’s illness.

(Image credit: Cheryl Gerber/AP)

You May Also Like

With Help From a Beer Maker, There’s a New Front Opening in the Battle Over School Masks

Sprinter Health Raises $33 Million in Series A Funding to Eliminate Barriers to Healthcare Through In-Home Lab Draws, Vitals Checks and COVID-19 Testing

Living Room Facelift: In Progress

Like a Lamborghini

FDA gives its 1st authorization for e-cigarettes

Six of the Greatest Arm Workouts for Women